Top

Cancer Causes & Control

Published in:

01-10-2010 | Original paper

Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006

Authors: Anne Marie McCarthy, Tamara Dumanovsky, Kala Visvanathan, Amy R. Kahn, Maria J. Schymura

Published in: Cancer Causes & Control | Issue 10/2010

Abstract

Background

Though cervical cancer rates have declined due to Pap screening, racial and socioeconomic disparities in cervical cancer incidence and mortality persist. This study assesses the relative impact of race/ethnicity and neighborhood poverty on cervical cancer incidence and mortality in New York City (NYC).

Methods

Invasive cervical cancer cases in NYC from 1995 to 2006 were identified along with demographic and socioeconomic measures. Odds ratios (OR) of late stage diagnosis were estimated using logistic regression. Hazard ratios (HR) of death were calculated using Cox proportional hazards regression.

Results

From 1995 to 2006 cervical cancer incidence and mortality rates decreased in NYC, though black and Hispanic women had higher incidence and mortality rates than white women. Puerto Ricans (OR = 1.55, 95% CI = 1.20–2.01) and blacks (OR = 1.34, 95% CI = 1.15–1.57) were more likely to be diagnosed with late stage disease than whites. In multivariate analysis, blacks had similar mortality risk (HR 1.07, 95% CI = 0.95–1.20) to whites while Puerto Ricans had increased risk (HR = 1.31, 95% CI = 1.10–1.55), and non-Puerto Rican Hispanics (HR = 0.54, 95% CI = 0.45–0.63) and Asian/PIs (HR = 0.64, 95% CI = 0.52–0.78) had reduced risk. Women living in high poverty neighborhoods had higher mortality than women in higher income neighborhoods (HR = 1.32, 95% CI = 1.16–1.52).

Conclusions

Black and Puerto Rican women in NYC are at greatest risk of dying from cervical cancer. Race/ethnicity is predictive of late stage diagnosis, while both race/ethnicity and neighborhood poverty are important predictors of cervical cancer mortality.

American Cancer Society (2008) Cancer facts and figures

Garner EIO (2003) Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12(3):242s–247PubMed

Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlander N, Horner M et al. (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER website 2008; Available at: http://seer.cancer.gov/csr/1975_2005/. Accessed 08, 2008

del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E (1999) Ethnic differences in patterns of care of Stage 1A1 and Stage 1A2 cervical cancer: A SEER database study. Gynecologic Oncol 75(1):113–117CrossRef

Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecologic Oncol 109(2, Suppl 1):S22–S30

Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357

Karpati A, Kerker B, Mostashari F, Singh T, Hajat A, Thorpe L et al (2004) Health disparities in New York City. New York City Department of Health and Mental Hygiene, New York

Kerker B, Kim M, Mostashari F, Thorpe L, Friedan T (2005) Women at risk: the health of women in New York City. New York City Department of Health and Mental Hygiene, New York

Wang JH, Sheppard VB, Schwartz MD, Liang W, Mandelblatt JS (2008) Disparities in cervical cancer screening between Asian American and Non-Hispanic White women. Cancer Epidemiol Biomark Prev 17(8):1968–1973CrossRef

10.

Klein RJ, Schoenborn CA (2001) Age adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes, no. 20. National Center for Health Statistics, Hyattsville, MD

11.

Efron B (1977) The efficiency of Cox’s likelihood function for censored data. J Am Stat Ass 72:557–565CrossRef

12.

Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ (2001) Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154(6):544–556CrossRefPubMed

13.

Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31(3):157–181CrossRefPubMed

14.

Bates JH, Hofer BM, Parikh-Patel A (2008) Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 113(10):2955–2963CrossRefPubMed

15.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG et al. (2005) Annual report to the Nation on the Status of Cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427

16.

Zapka JG, Taplin SH, Solberg LI, Manos MM (2003) A framework for improving the quality of cancer care. Cancer Epidemiol Biomarkers Prev 12(1):4–13PubMed

17.

Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J (2003) Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 60(3):294–331

18.

Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMed

19.

Spence AR, Goggin P, Franco EL (2007) Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 45(2–3):93–106CrossRefPubMed

20.

Olson E, Van Wye G, Kerker B, Thorpe L (2006) Cervical cancer screening in New York City. NYC Vital Signs 5(3):1–4

21.

Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004) Some methodologic lessons learned from cancer screening research. Cancer 101(S5):1131–1145

22.

Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: Findings from the SEER–Medicare linked data cohorts. Gynecol Oncol 102(2):278–284

23.

Johnson CE, Mues KE, Mayne SL, Kiblawi AN (2008) Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the health belief model. J Lower Genital Tract Disease 12(3):232–241CrossRef

24.

Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W (2005) Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 105(6):1323–1328PubMed

25.

Newmann SJ, Garner EO (2005) Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16(1):63–70CrossRefPubMed

26.

Patel DA, Barnholtz-Sloan JS, Patel MK, Malone J, John M, Chuba PJ, Schwartz K (2005) A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of surveillance, epidemiology, and end results data. Gynecol Oncol 97(2):550–558CrossRefPubMed

27.

Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR (2006) Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995–2001. J Women’s Health 15(8):941–951CrossRef

28.

Leath III CA, Straughn J, Michael J, Kirby TO, Huggins A, Partridge EE, Parham GP (2005) Predictors of outcomes for women with cervical carcinoma. Gynecologic Oncol 99(2):432–436

29.

Thoms W, Unger E, Johnson P, Spann C, Hunter S, Smith R et al (1995) Cervical cancer survival in a high risk urban population. Cancer 76(12):2518–2523CrossRefPubMed

30.

Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG (2009) Disparities in survival among women with invasive cervical cancer. Cancer 115(1):166–178CrossRefPubMed

31.

Movva S, Noone A, Banerjee M, Patel D, Schwartz K, Yee C et al (2008) Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 112(6):1264–1271CrossRefPubMed

32.

Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057CrossRefPubMed

33.

Lin S, Clarke C, Prehn A, Glaser S, West D, O’Malley C (2002) Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer 94(4):1175–1182CrossRefPubMed

34.

Abraído-Lanza AF, Chao MT, Flórez KR (2005) Do healthy behaviors decline with greater acculturation?: implications for the Latino mortality paradox. Soc Sci Med 61(6):1243–1255

35.

Lobo AP, Flores RJO, Salvo JJ (2002) The impact of Hispanic growth on the racial/ethnic composition of New York City neighborhoods. Urban Aff Rev 37(5):703–727

36.

Lara M, Gamboa C, Kahramanian MI, Morales LS, Hayes Bautista DE (2005) Acculturation and latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health 26(1):367–397

37.

Singh G, Miller B, Hankey B, Edwards B (2004) Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057

38.

Krieger N, Chen JT, Waterman PD, Soobader M, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the public health disparities geocoding project. Am J Epidemiol 156(5):471–482

Title: Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006
Authors: Anne Marie McCarthy
Tamara Dumanovsky
Kala Visvanathan
Amy R. Kahn
Maria J. Schymura
Publication date: 01-10-2010
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 10/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-010-9593-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2010

Vitamin and mineral use and risk of prostate cancer: misleading?

Male infertility and prostate cancer risk: a nested case–control study

Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma

Cancer risk in Norwegian world class athletes

Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study

Childhood cancer mortality and socioeconomic position in South Korea: a national population-based birth cohort study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer